Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impacts of the STING-IFNAR1-STAT1-IRF1 pathway on the cellular immune reaction induced by fractionated irradiation.
Du J, Kageyama SI, Yamashita R, Hirata H, Hakozaki Y, Okumura M, Motegi A, Hojo H, Nakamura M, Hirano Y, Sunakawa H, Minamide T, Kotani D, Tanaka K, Yano T, Kojima T, Ohashi A, Tsuchihara K, Akimoto T. Du J, et al. Among authors: nakamura m. Cancer Sci. 2022 Apr;113(4):1352-1361. doi: 10.1111/cas.15297. Epub 2022 Feb 20. Cancer Sci. 2022. PMID: 35133062 Free PMC article.
Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy.
Kibe Y, Nakamura N, Kuno H, Hiyama T, Hayashi R, Zenda S, Motegi A, Hojo H, Nakamura M, Ariji T, Oyoshi H, Akimoto T. Kibe Y, et al. Among authors: nakamura m, nakamura n. Int J Clin Oncol. 2019 Oct;24(10):1182-1189. doi: 10.1007/s10147-019-01479-x. Epub 2019 Jul 9. Int J Clin Oncol. 2019. PMID: 31289957
Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
Raturi V, Hojo H, Bhatt MLB, Suhel M, Wu CT, Bei Y, Nakamura M, Okumura M, Zhang H, Parmar D, Badajena A, Singh R, Kumar S, Katiyar T, Gaur J. Raturi V, et al. Among authors: nakamura m. Head Neck. 2020 May;42(5):1045-1056. doi: 10.1002/hed.26083. Epub 2020 Jan 30. Head Neck. 2020. PMID: 31997432
Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation.
Okumura M, Motegi A, Zenda S, Nakamura N, Hojo H, Nakamura M, Hirano Y, Kageyama SI, Arahira S, Parshuram RV, Kuno H, Hayashi R, Tahara M, Itoh Y, Naganawa S, Akimoto T. Okumura M, et al. Among authors: nakamura m, nakamura n. Head Neck. 2020 Aug;42(8):1775-1782. doi: 10.1002/hed.26092. Epub 2020 Feb 7. Head Neck. 2020. PMID: 32031301
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
Bando H, Kotani D, Tsushima T, Hara H, Kadowaki S, Kato K, Chin K, Yamaguchi K, Kageyama SI, Hojo H, Nakamura M, Tachibana H, Wakabayashi M, Fukutani M, Togashi Y, Fuse N, Nishikawa H, Kojima T. Bando H, et al. Among authors: nakamura m. BMC Cancer. 2020 Apr 20;20(1):336. doi: 10.1186/s12885-020-06716-5. BMC Cancer. 2020. PMID: 32312286 Free PMC article. Clinical Trial.
Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP, Hojo H, Hotta K, Baba H, Takahashi R, Rachi T, Nakamura N, Zenda S, Motegi A, Tachibana H, Ariji T, Motegi K, Nakamura M, Okumura M, Hirano Y, Akimoto T. Raturi VP, et al. Among authors: nakamura m, nakamura n. Radiat Oncol. 2020 Jun 22;15(1):157. doi: 10.1186/s13014-020-01592-6. Radiat Oncol. 2020. PMID: 32571379 Free PMC article.
Identification of the mutation signature of the cancer genome caused by irradiation.
Kageyama SI, Du J, Kaneko S, Hamamoto R, Yamaguchi S, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Tsuchihara K, Akimoto T. Kageyama SI, et al. Among authors: nakamura m. Radiother Oncol. 2021 Feb;155:10-16. doi: 10.1016/j.radonc.2020.10.020. Epub 2020 Oct 17. Radiother Oncol. 2021. PMID: 33075393 Free article.
15,245 results
You have reached the last available page of results. Please see the User Guide for more information.